Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two‐year prospective surveillance study
Open Access
- 20 February 2023
- journal article
- research article
- Published by Wiley in Epilepsia Open
- Vol. 8 (2) , 411-424
Abstract
Objective: The aim of this study was to provide seizure etiology, semiology, underlying conditions, and out‐of‐ and in‐hospital diagnostics, treatment, and outcome data on children with out‐of‐ or in‐hospital‐onset status epilepticus (SE) according to the International League Against Epilepsy definition that required admission to the pediatric intensive care unit (PICU) for ≥4 hours.Methods: This prospective national surveillance study on SE in childhood and adolescence was conducted over 2 years (07/2019‐06/2021).Results: This study examined 481 SE episodes in 481 children with a median age of 43 months (1 month to 17 years 11 months), of which 46.2% were female and 50.7% had a previous seizure history. The most frequent acute SE cause was a prolonged, complicated febrile seizure (20.6%). The most common initial seizure types were generalized seizures (49.9%), focal seizures (18.0%), and unknown types (12.1%); 40.5% of patients suffered from refractory SE and 5.0% from super‐refractory SE. The three most common medications administered by nonmedically trained individuals were diazepam, midazolam, and antipyretics. The three most frequent anti‐seizure medications (ASMs) administered by the emergency physician were midazolam, diazepam, and propofol. The three most common ASMs used in the clinical setting were midazolam, levetiracetam, and phenobarbital. New ASMs administered included lacosamide, brivaracetam, perampanel, stiripentol, and eslicarbazepine. Status epilepticus terminated in 16.0% in the preclinical setting, 19.1% in the emergency department, and 58.0% in the PICU; the outcome was unknown for 6.9%. The median PICU stay length was 2 (1–121) days. The median modified Rankin scale was 1 (0–5) on admission and 2 (0–6) at discharge. New neurological deficits after SE were observed in 6.2%. The mortality rate was 3.5%.Significance: This study provides current real‐world out‐of‐ and in‐hospital data on pediatric SE requiring PICU admission. New ASMs are more frequently used in this population. This knowledge may help generate a more standardized approach.Keywords
This publication has 32 references indexed in Scilit:
- Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticusEuropean Journal of Paediatric Neurology, 2015
- Guidelines for the Evaluation and Management of Status EpilepticusNeurocritical Care, 2012
- Outcome of status epilepticus in children treated in the intensive care unit: A study of 302 casesEpilepsia, 2011
- Prospective study of new-onset seizures presenting as status epilepticus in childhoodNeurology, 2010
- Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based studyThe Lancet Neurology, 2008
- The Epidemiology of Convulsive Status Epilepticus in Children: A Critical ReviewEpilepsia, 2007
- Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review)Neurology, 2006
- Outcome of paediatric convulsive status epilepticus: a systematic reviewThe Lancet Neurology, 2006
- Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based studyThe Lancet, 2006
- Improving the Assessment of Outcomes in StrokeStroke, 2002